A collection of compelling interviews conducted with rheumatologists and rheumatology professionals focusing on their experiences thus far in the COVID-19 pandemic.
Pharmacy Team Combats COVID-19 in NYC: Q&A with Mark J. Sinnett, PharmD, FASHP
The outbreak of the SARS-CoV-2 virus is disrupting patient care all over the world. In the U.S., many providers have had to adapt to new social distancing measures to care for patients, but struggles remain. Mark J. Sinnett, PharmD, FASHP, director of clinical and educational pharmacy services and director of the Center for Pharmacotherapy Research…
Collaborating at the Leadership Level: Q&A with Lisa Fitzgerald, MD, & George Tsokos, MD
Rheumatology leaders are adapting to telemedicine and other modified collaborations to adjust patient care and research during the COVID-19 pandemic…
Adjusting Patient Care to Social Distancing: Q&A with Bryant Uy, MPH, PA-C
Working within a community experiencing a high number of confirmed COVID-19 cases is requiring a strategic approach to manage patient care…
Mobilizing a Long-Term Telemedicine Solution: Q&A with Karen Ferguson
Looking beyond the COVID-19 pandemic, one practice has combined its telemedicine functionality with long-term workflow solutions, including telemedicine technology that integrates with its electronic health records system…
Transitioning to a Virtual Practice: Q&A with Lisa Criscione-Schreiber, MD, MEd
A quick shift to virtual teaching and patient care is just one of many changes rheumatologists at Duke University are adapting to during the COVID-19 pandemic…
Join the ACR COVID-19 Clinical Guidance Town Hall: May 6
In response to the recently published clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic, the ACR is hosting a virtual town hall for the rheumatology community on Wednesday, May 6, at 7–8 p.m. EDT, to review the recommendations. Moderated by ACR President Ellen M. Gravallese, MD, and ACR…
Fear & Hope in the Era of the Modern Plague
This plague has affected each one of us, our families and friends, and abruptly, it has altered the way we relate to one another.
3 U.S. Children with COVID-19 Have Rare Inflammatory Syndrome
CHICAGO (Reuters)—Three U.S. children infected with the coronavirus are being treated for a rare inflammatory syndrome that appears similar to one that has raised concerns by doctors in Britain, Italy and Spain, a specialist treating the patients told Reuters. All three—who range in age from 6 months to 8 years—have undergone treatment at Columbia University…
Trial of Gilead’s Potential Coronavirus Treatment Running Ahead of Schedule
(Reuters)—A key U.S. government trial of Gilead Sciences Inc.’s experimental coronavirus treatment may yield results as early as mid-May, according to the study’s lead investigator, after doctors clamored to enroll their patients in the study. Preliminary findings from the randomized trial of the antiviral drug remdesivir, begun in February by the National Institute of Allergy…
- « Previous Page
- 1
- …
- 20
- 21
- 22
- 23
- 24
- …
- 27
- Next Page »